Cargando…
Dapagliflozin-Induced Acute-on-Chronic Liver Injury
Sodium-glucose cotransporter 2 inhibitors are a new class of oral hypoglycemic agents, and thus safety data are limited. We present a 48-year-old woman with type 2 diabetes mellitus and Child’s Class A cirrhosis secondary to nonalcoholic steatohepatitis presenting with jaundice and acute cholestatic...
Autores principales: | Levine, Joshua A., Lo, Amy Ann, Wallia, Amisha, Rogers, Melinda, VanWagner, Lisa B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Gastroenterology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5171930/ https://www.ncbi.nlm.nih.gov/pubmed/28008402 http://dx.doi.org/10.14309/crj.2016.142 |
Ejemplares similares
-
Development of a Predictive Model for Hyperglycemia in Nondiabetic Recipients After Liver Transplantation
por: Zelada, Henry, et al.
Publicado: (2018) -
Is fatty liver a risk marker for heart failure?
por: VanWagner, Lisa B.
Publicado: (2017) -
Survival effects of physical activity on mortality among persons with liver disease()
por: Loprinzi, Paul D., et al.
Publicado: (2015) -
Dapagliflozin for prednisone‐induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease
por: Gerards, Maaike C., et al.
Publicado: (2018) -
Liver injury following SARS-CoV-2 vaccination: A multicenter case series
por: Shroff, Hersh, et al.
Publicado: (2022)